Variant report

Variant	esv11358
Chromosome Location	chr10:118766138-118768926
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr10:118766207-118767025	K562	blood:	n/a	n/a
2	ATF3	chr10:118766577-118766978	K562	blood:	n/a	n/a
3	BACH1	chr10:118766594-118766930	H1-hESC	embryonic stem cell:	n/a	chr10:118766757-118766771 chr10:118766747-118766761
4	BACH1	chr10:118766557-118766983	K562	blood:	n/a	chr10:118766757-118766771 chr10:118766747-118766761
5	CBX3	chr10:118766020-118767106	HCT-116	colon:	n/a	n/a
6	CBX3	chr10:118766493-118767089	HCT-116	colon:	n/a	n/a
7	CCNT2	chr10:118766082-118766357	K562	blood:	n/a	n/a
8	CEBPB	chr10:118766520-118766925	A549	lung:	n/a	n/a
9	CEBPB	chr10:118766520-118766978	A549	lung:	n/a	n/a
10	CEBPB	chr10:118766570-118766916	A549	lung:	n/a	n/a
11	CEBPB	chr10:118766609-118766918	K562	blood:	n/a	n/a
12	CEBPB	chr10:118766563-118766832	MCF-7	breast:	n/a	n/a
13	CEBPB	chr10:118766597-118766972	ECC-1	luminal epithelium:	n/a	n/a
14	CEBPB	chr10:118766280-118766914	K562	blood:	n/a	n/a
15	CEBPB	chr10:118766449-118767008	HCT-116	colon:	n/a	n/a
16	CEBPB	chr10:118766559-118766936	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr10:118766533-118767036	MCF-7	breast:	n/a	n/a
18	CEBPB	chr10:118766575-118766895	IMR90	lung:	n/a	n/a
19	CTCF	chr10:118766633-118766739	K562	blood:	n/a	n/a
20	CTCF	chr10:118767940-118768090	HPF	lung:	n/a	n/a
21	CTCF	chr10:118766120-118766270	HCT-116	colon:	n/a	n/a
22	CUX1	chr10:118766185-118766956	K562	blood:	n/a	n/a
23	E2F4	chr10:118766297-118767185	MCF10A-Er-Src	breast:	n/a	n/a
24	EP300	chr10:118766579-118766898	SK-N-SH_RA	brain:	n/a	chr10:118766750-118766759 chr10:118766749-118766758
25	EP300	chr10:118766540-118766996	ECC-1	luminal epithelium:	n/a	chr10:118766750-118766759 chr10:118766749-118766758
26	EP300	chr10:118766488-118767064	SK-N-SH	brain:	n/a	chr10:118766750-118766759 chr10:118766749-118766758
27	EP300	chr10:118766456-118767123	SK-N-SH	brain:	n/a	chr10:118766750-118766759 chr10:118766749-118766758
28	EP300	chr10:118766578-118766771	K562	blood:	n/a	chr10:118766750-118766759 chr10:118766749-118766758
29	EP300	chr10:118766378-118767132	K562	blood:	n/a	chr10:118766750-118766759 chr10:118766749-118766758
30	EP300	chr10:118766546-118766926	SK-N-SH_RA	brain:	n/a	chr10:118766750-118766759 chr10:118766749-118766758
31	EP300	chr10:118766456-118766950	Hela-S3	cervix:	n/a	chr10:118766750-118766759 chr10:118766749-118766758
32	EP300	chr10:118766494-118766970	A549	lung:	n/a	chr10:118766750-118766759 chr10:118766749-118766758
33	FOS	chr10:118766364-118766949	MCF10A-Er-Src	breast:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766748-118766759 chr10:118766749-118766758 chr10:118766480-118766487 chr10:118766758-118766770 chr10:118766750-118766759
34	FOS	chr10:118766569-118766941	K562	blood:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766748-118766759 chr10:118766749-118766758 chr10:118766758-118766770 chr10:118766750-118766759
35	FOS	chr10:118766366-118767015	HUVEC	blood vessel:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766748-118766759 chr10:118766749-118766758 chr10:118766480-118766487 chr10:118766758-118766770 chr10:118766750-118766759
36	FOS	chr10:118766363-118767071	MCF10A-Er-Src	breast:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766748-118766759 chr10:118766749-118766758 chr10:118766480-118766487 chr10:118766758-118766770 chr10:118766750-118766759
37	FOS	chr10:118766555-118766972	MCF10A-Er-Src	breast:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766748-118766759 chr10:118766749-118766758 chr10:118766758-118766770 chr10:118766750-118766759
38	FOS	chr10:118766580-118766935	Hela-S3	cervix:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766748-118766759 chr10:118766749-118766758 chr10:118766758-118766770 chr10:118766750-118766759
39	FOS	chr10:118766172-118766968	MCF10A-Er-Src	breast:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766748-118766759 chr10:118766749-118766758 chr10:118766480-118766487 chr10:118766758-118766770 chr10:118766750-118766759
40	FOSL1	chr10:118766016-118767292	HCT-116	colon:	n/a	chr10:118766748-118766759 chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766480-118766487 chr10:118766758-118766770 chr10:118766750-118766759
41	FOSL1	chr10:118766077-118767122	HCT-116	colon:	n/a	chr10:118766748-118766759 chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766480-118766487 chr10:118766758-118766770 chr10:118766750-118766759
42	FOSL1	chr10:118766572-118766939	K562	blood:	n/a	chr10:118766748-118766759 chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766758-118766770 chr10:118766750-118766759
43	FOSL2	chr10:118766439-118767037	SK-N-SH	brain:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766480-118766487 chr10:118766758-118766770 chr10:118766750-118766759
44	FOSL2	chr10:118766418-118767099	MCF-7	breast:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766480-118766487 chr10:118766758-118766770 chr10:118766750-118766759
45	FOSL2	chr10:118766549-118766915	SK-N-SH	brain:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766758-118766770 chr10:118766750-118766759
46	FOSL2	chr10:118766481-118767089	MCF-7	breast:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766758-118766770 chr10:118766750-118766759
47	FOSL2	chr10:118766628-118766863	HepG2	liver:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766758-118766770 chr10:118766750-118766759
48	FOSL2	chr10:118766554-118766926	A549	lung:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766758-118766770 chr10:118766750-118766759
49	FOSL2	chr10:118766238-118767121	A549	lung:	n/a	chr10:118766750-118766758 chr10:118766759-118766769 chr10:118766760-118766768 chr10:118766749-118766759 chr10:118766748-118766760 chr10:118766761-118766772 chr10:118766751-118766758 chr10:118766749-118766758 chr10:118766480-118766487 chr10:118766758-118766770 chr10:118766750-118766759
50	GATA3	chr10:118766418-118767033	A549	lung:	n/a	chr10:118766761-118766770

No.	Distal block	Cell Line	Cell type
1	chr10:118765114..118768175-chr10:118770999..118774519,3	K562	blood:
2	chr10:118763331..118765453-chr10:118765627..118768169,2	MCF-7	breast:
3	chr10:118764547..118766196-chr10:118768228..118770717,2	MCF-7	breast:
4	chr10:118718724..118721628-chr10:118764683..118766816,3	MCF-7	breast:

Variant related genes	Relation type
KIAA1598	TF binding region
ENSG00000187164	chromatin interactions

Extended variants
information (count: 85 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:85 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs566604925	chr10:118766147-118766148	Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs545233057	chr10:118766161-118766162	Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs117780732	chr10:118766183-118766184	Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs192967734	chr10:118766194-118766195	Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs572637168	chr10:118766205-118766206	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs540267067	chr10:118766218-118766219	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs553475965	chr10:118766313-118766314	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs573688310	chr10:118766323-118766324	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs372814411	chr10:118766340-118766341	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs543531255	chr10:118766358-118766359	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs377650360	chr10:118766384-118766385	Flanking Active TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs542696134	chr10:118766458-118766459	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs562693685	chr10:118766473-118766474	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs531498666	chr10:118766543-118766544	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs35206101	chr10:118766553-118766554	Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs545208283	chr10:118766632-118766633	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs74159021	chr10:118766680-118766681	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs185189628	chr10:118766681-118766682	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs547811353	chr10:118766682-118766683	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs567513482	chr10:118766794-118766795	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs368441221	chr10:118766821-118766822	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs541551219	chr10:118766835-118766836	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs190564792	chr10:118766877-118766878	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs76638401	chr10:118766883-118766884	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs530137603	chr10:118767004-118767005	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs182365723	chr10:118767032-118767033	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs79235303	chr10:118767033-118767034	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs111419069	chr10:118767038-118767039	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs113110509	chr10:118767047-118767048	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs184761089	chr10:118767051-118767052	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs10749231	chr10:118767052-118767053	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs558864976	chr10:118767080-118767081	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs35941784	chr10:118767091-118767092	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs17095519	chr10:118767117-118767118	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs568904945	chr10:118767120-118767121	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs373794401	chr10:118767128-118767129	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs12569743	chr10:118767154-118767155	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs140366722	chr10:118767162-118767163	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs563523107	chr10:118767190-118767191	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs565555784	chr10:118767200-118767201	Weak transcription Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs117967254	chr10:118767207-118767208	Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs573527323	chr10:118767225-118767226	Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs188308809	chr10:118767254-118767255	Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs556328536	chr10:118767290-118767291	Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs369671670	chr10:118767294-118767295	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs10736262	chr10:118767305-118767306	Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs545271489	chr10:118767416-118767417	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs564922874	chr10:118767422-118767423	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs572316193	chr10:118767444-118767445	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs540923460	chr10:118767495-118767496	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Paraganglioma	17535989	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	16608533	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cornelia de Lange syndrome	24599119	CNVD
T-cell lymphomas	19863542	CNVD
Breast cancer	16397240	CNVD
Urothelial carcinoma	21177765	CNVD
Chronic lymphocytic leukemia	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Hepatocellular carcinoma	16750200	CNVD
Barrett''s syndrome	19417022	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Neuroticism	17667963	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Sezary syndrome	18413736	CNVD

Chromatin state (count:53 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:118763400-118766200	Active TSS	A549	lung
2	chr10:118763600-118766200	Active TSS	ES-I3 Cell Line	embryonic stem cell
3	chr10:118765400-118766200	Weak transcription	NHDF-Ad	bronchial
4	chr10:118765400-118766800	Enhancers	Primary monocytes fromperipheralblood	blood
5	chr10:118765600-118766200	Enhancers	Brain Hippocampus Middle	brain
6	chr10:118765600-118766200	Enhancers	Fetal Brain Male	brain
7	chr10:118765600-118766200	Active TSS	Hela-S3	cervix
8	chr10:118765600-118766200	Active TSS	K562	blood
9	chr10:118765600-118766400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr10:118765600-118766400	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr10:118765600-118766400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr10:118765600-118766400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr10:118765600-118766400	Enhancers	Liver	Liver
14	chr10:118765600-118766400	Enhancers	Brain Cingulate Gyrus	brain
15	chr10:118765600-118766400	Active TSS	Brain Germinal Matrix	brain
16	chr10:118765600-118766400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
17	chr10:118765600-118766400	Enhancers	NH-A	brain
18	chr10:118765600-118766600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
19	chr10:118765600-118766600	Weak transcription	Stomach Mucosa	stomach
20	chr10:118765600-118766800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
21	chr10:118765600-118766800	Enhancers	HUVEC	blood vessel
22	chr10:118765600-118767000	Enhancers	Brain Substantia Nigra	brain
23	chr10:118765600-118767200	Enhancers	Monocytes-CD14+_RO01746	blood
24	chr10:118765800-118766200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
25	chr10:118765800-118766400	Enhancers	Brain Inferior Temporal Lobe	brain
26	chr10:118765800-118766800	Enhancers	HepG2	liver
27	chr10:118766000-118766600	Enhancers	HMEC	breast
28	chr10:118766200-118766400	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
29	chr10:118766200-118766400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
30	chr10:118766200-118766400	Enhancers	Muscle Satellite Cultured Cells	--
31	chr10:118766200-118766400	Flanking Active TSS	Brain Hippocampus Middle	brain
32	chr10:118766200-118766400	Enhancers	Placenta	Placenta
33	chr10:118766200-118766400	Flanking Active TSS	Hela-S3	cervix
34	chr10:118766200-118766400	Enhancers	HSMM	muscle
35	chr10:118766200-118766400	Flanking Active TSS	K562	blood
36	chr10:118766200-118766400	Enhancers	NHEK	skin
37	chr10:118766200-118766600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
38	chr10:118766200-118766800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
39	chr10:118766200-118767200	Flanking Active TSS	A549	lung
40	chr10:118766400-118766600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
41	chr10:118766400-118766600	Enhancers	Brain Germinal Matrix	brain
42	chr10:118766400-118766600	Enhancers	Brain Hippocampus Middle	brain
43	chr10:118766400-118766600	Enhancers	Pancreatic Islets	Pancreatic Islet
44	chr10:118766400-118766600	Enhancers	Hela-S3	cervix
45	chr10:118766400-118766600	Active TSS	K562	blood
46	chr10:118766400-118766600	Enhancers	NHDF-Ad	bronchial
47	chr10:118766400-118766800	Enhancers	ES-I3 Cell Line	embryonic stem cell
48	chr10:118766600-118766800	Enhancers	HUES48 Cell Line	embryonic stem cell
49	chr10:118766600-118767200	Enhancers	K562	blood
50	chr10:118766600-118768200	Weak transcription	Brain Hippocampus Middle	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links